🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
60.41
-1.01 (-1.64%)
At close: Nov 20, 2026, 4:00 PM EST
60.41
0.00 (0.00%)
After-hours: Nov 20, 2026, 4:15 PM EST

BioMarin Pharmaceutical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,6553,2212,8542,4192,0961,846
Revenue Growth
18.14%12.87%17.97%15.42%13.53%-0.76%
Cost of Revenue
1,7101,5201,3271,2791,1531,099
Gross Profit
1,9451,7011,5261,140943.41746.97
Selling, General & Admin
1,1651,0311,009892.41823.24759.38
Amortization of Goodwill & Intangibles
182.2819.3943.2662.2165.4961.91
Operating Expenses
1,3481,0501,052954.62888.73821.28
Operating Income
597.44650.73474.21185.7754.68-74.32
Interest Expense
-136.66-10.9-12.67-17.34-15.97-15.34
Interest & Investment Income
56.8874.974.8858.3418.0310.48
Currency Exchange Gain (Loss)
-----11.4-
Other Non Operating Income (Expenses)
9.589-4.67-38.22-2.0611.85
EBT Excluding Unusual Items
527.23723.73531.76188.5643.28-67.32
Merger & Restructuring Charges
-416.84-241.25----
Gain (Loss) on Sale of Assets
--10-108-
Other Unusual Items
-----1.7-8.03
Pretax Income
43.67482.48541.76188.56149.58-75.35
Income Tax Expense
62.78133.58114.920.928.02-11.27
Net Income
-19.12348.9426.86167.65141.56-64.08
Net Income to Common
-19.12348.9426.86167.65141.56-64.08
Net Income Growth
--18.26%154.62%18.43%--
Shares Outstanding (Basic)
193192190188185183
Shares Outstanding (Diluted)
193197197192189183
Shares Change
-2.00%0.35%2.67%1.39%3.34%-4.61%
EPS (Basic)
-0.101.822.250.890.76-0.35
EPS (Diluted)
-0.101.802.210.870.75-0.35
EPS Growth
--18.24%153.71%16.00%--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
557.86724.96487.4262.5754.94208.96
Free Cash Flow Per Share
2.893.672.480.330.291.14
Gross Margin
53.21%52.81%53.49%47.14%45.01%40.46%
Operating Margin
16.35%20.20%16.62%7.68%2.61%-4.03%
Profit Margin
-0.52%10.83%14.96%6.93%6.75%-3.47%
Free Cash Flow Margin
15.26%22.50%17.08%2.59%2.62%11.32%
EBITDA
854.99722.89570.64290.16156.6533.72
EBITDA Margin
23.39%22.44%19.99%11.99%7.47%1.83%
D&A For EBITDA
257.5572.1696.43104.39101.97108.04
EBIT
597.44650.73474.21185.7754.68-74.32
EBIT Margin
16.35%20.20%16.62%7.68%2.61%-4.03%
Effective Tax Rate
143.78%27.69%21.21%11.09%5.36%-
Revenue as Reported
3,6553,2212,8542,4192,0961,846
Advertising Expenses
-50.534.527.825.230.2
SEC Filings: 10-K · 10-Q